We are live on ! Find out more
SI

Scharf Investments Portfolio holdings

AUM $3.03B
1-Year Est. Return 7.75%
This Fund
S&P 500
This Quarter Est. Return
-1.48%
1 Year Est. Return
+7.75%
3 Year Est. Return
+55.03%
5 Year Est. Return
+80.17%
10 Year Est. Return
+289.59%
AUM
$3.17B
AUM Growth
-$125M
Cap. Flow
-$67.7M
Cap. Flow %
-2.14%
Top 10 Hldgs %
56.23%
Holding
51
New
2
Increased
22
Reduced
22
Closed
3

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$56.2M
2
FISV
Fiserv Inc
FISV
+$42M
3
VVV icon
Valvoline
VVV
+$16.9M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16M
5
MLKN icon
MillerKnoll
MLKN
+$10.7M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$84.1M
2
DGX icon
Quest Diagnostics
DGX
+$40M
3
MSFT icon
Microsoft
MSFT
+$29.9M
4
ORCL icon
Oracle
ORCL
+$20M
5
KSU
Kansas City Southern
KSU
+$7.16M

Sector Composition

Rank Sector Weight
1 Healthcare 24.87%
2 Technology 21.44%
3 Financials 14.59%
4 Consumer Discretionary 12.14%
5 Communication Services 12.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
51
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-457,897
Closed -$84.1M
1 2
3

Similar funds

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Scharf Investments's Q3 2021 Portfolio in Review

As of Q3 2021, Scharf Investments held 51 positions worth $3.17B, down 3.8% from $3.29B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Scharf Investments's Q3 2021 filing shows 2 new, 22 increased, 22 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 483,015 shares worth $58M. The largest sale was Alexion Pharmaceuticals, an estimated $84.1M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Scharf Investments's largest Q3 2021 buy was AstraZeneca: 483,015 shares worth $58M.
  • Scharf Investments added most to Fiserv Inc in Q3 2021, an estimated $42M increase.
  • Scharf Investments's biggest Q3 2021 reduction was Quest Diagnostics, cutting an estimated $40M.
  • Scharf Investments fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $84.1M.
  • Scharf Investments's ten largest holdings make up 56% of its $3.17B portfolio in Q3 2021.
  • Scharf Investments opened 2 new positions and closed 3 in Q3 2021.
  • Scharf Investments's portfolio value fell 3.8% quarter-over-quarter to $3.17B.

Based on Scharf Investments's 13F filing for Q3 2021, filed 14 Oct 2021.